DH
Definitive Healthcare Corp
0.9862$
+5.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.3% | -0.9% | -21.4% | -16.9% | -7.8% | -25.8% | -4.8% | -1.9% | -2.7% | -30.0% | -3.5% | |
| – | +1.3% | -0.5% | -2.7% | +0.1% | +0.4% | -26.1% | -8.9% | -1.2% | +4.6% | -9.4% | +2.9% | |
| – | +69.1% | -19.1% | +14.1% | +13.8% | -23.4% | +0.7% | -23.7% | +33.8% | +51.1% | -3.7% | +8.4% | |
| – | +0.3% | -4.2% | +0.5% | +3.0% | -5.0% | -30.8% | -8.2% | +0.9% | -2.7% | -1.5% | +3.1% | |
| – | +43.4% | -4.4% | -22.0% | -19.1% | +48.9% | -19.4% | -12.6% | -8.4% | +51.2% | -24.3% | -20.7% | |
| – | -127.6% | – | -288,400,100.0% | – | – | – | – | – | – | – | – | |
| – | +0.1% | +0.7% | -33.6% | -31.8% | -19.8% | -44.9% | +0.0% | +0.0% | -9.0% | -100.0% | – | |
| – | -3.8% | -1.6% | -3.4% | -4.1% | +1.2% | -4.4% | -4.7% | -4.1% | -4.8% | -4.9% | -5.4% | |
| – | +1.7% | -1.9% | -12.8% | -9.3% | -0.8% | -22.7% | -3.7% | +1.9% | -2.6% | -9.1% | -4.7% | |
| – | +16.0% | -3.3% | -7.0% | -3.5% | +8.8% | -3.2% | -3.1% | +1.7% | +1.9% | -10.5% | -8.1% | |
| – | +0.7% | +0.4% | +0.3% | +0.8% | -0.5% | -30.9% | +0.3% | +1.8% | +0.2% | -0.2% | 0.0% | |
| – | +4.0% | -15.4% | +24.2% | +63.9% | +8.1% | -23.6% | -3.9% | +8.5% | -58.0% | +67.5% | -24.8% | |
| – | -1.3% | -1.4% | -1.4% | -1.4% | -1.4% | -29.2% | -1.3% | -1.3% | -1.3% | -1.3% | -1.4% | |
| – | -0.2% | -0.1% | -25.0% | -21.4% | -12.3% | -27.4% | -5.9% | -6.2% | -1.3% | -48.0% | -1.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.7% | +0.9% | +0.3% | -1.2% | -1.2% | -1.9% | -5.3% | -2.8% | -0.4% | +1.3% | +1.1% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.